Linked Life Data

19230848

Source:http://linkedlifedata.com/resource/pubmed/id/19230848

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-4-6
pubmed:abstractText
To investigate whether experimental allergic conjunctivitis (EC) can be suppressed by treatment with the immunomodulatory drug FTY720, which reduces the recruitment of effector T cells into inflammatory sites.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1095-8355
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
534-41
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
pubmed:affiliation
Department of Ophthalmology and Visual Science, Kochi Medical School, Kohasu, Oko-cho, Nankoku-city, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't